Nuzenio

Structure Therapeutics

Structure Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Structure Therapeutics (GPCR) Is Up 10.6% After Advancing Oral Obesity Drug Into Phase 3 Trial - simplywall.stsimplywall.st · Sat, 08 Aug 2026 17:32:25 GMT Structure Therapeutics Chief Commercial Officer John Joseph Berrios files initial beneficial ownership statement - BitgetBitget · Fri, 07 Aug 2026 20:56:15 GMT Citigroup Cuts Structure Therapeutics (NASDAQ:GPCR) Price Target to $97.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 20:34:13 GMT Structure Therapeutics (GPCR) awards options and RSUs to its CCO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:09:08 GMT Structure Therapeutics Inc. (GPCR) files initial Form 3 for CCO - Stock TitanStock Titan · Fri, 07 Aug 2026 20:07:09 GMT Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:20:29 GMT Structure Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 23:41:33 GMT Structure Therapeutics (Nasdaq: GPCR) reports $182.1M H1 loss and $1.34B cash - Stock TitanStock Titan · Thu, 06 Aug 2026 20:29:54 GMT

Timeline

Sat, 08 Aug 2026 17:32:25 GMTStructure Therapeutics (GPCR) Is Up 10.6% After Advancing Oral Obesity Drug Into Phase 3 Trial - simplywall.st

Fri, 07 Aug 2026 20:56:15 GMTStructure Therapeutics Chief Commercial Officer John Joseph Berrios files initial beneficial ownership statement - Bitget

Fri, 07 Aug 2026 20:34:13 GMTCitigroup Cuts Structure Therapeutics (NASDAQ:GPCR) Price Target to $97.00 - MarketBeat

Fri, 07 Aug 2026 20:09:08 GMTStructure Therapeutics (GPCR) awards options and RSUs to its CCO - Stock Titan

Fri, 07 Aug 2026 20:07:09 GMTStructure Therapeutics Inc. (GPCR) files initial Form 3 for CCO - Stock Titan

Fri, 07 Aug 2026 08:20:29 GMTStructure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

GPCR23 live mentions Structure Therapeutics Inc13 live mentions NASDAQ8 live mentions Therapeutics4 live mentions Stock Titan Structure4 live mentions Sponsored ADR4 live mentions June4 live mentions Inc3 live mentions Stock Titan Stock3 live mentions Titan3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Structure Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.